Answer:
Suppose an abundance of hunting decreases the number of foxes in the ecosystem. Which of the following is the most likely impact of this decline in the fox population?
Once there is abundance decrease in hunting number of foxes in the ecosystem, there would be an increase in the population of foxes as a result of increase in birth rate and no death rate recorded, once there is unavailability in either predator and prey relationship it would benefit one, just as in the case of foxes mentioned above, since there is decrease in hunting number, hence; increases in number of foxes population
Explanation:
Parental Phenotypes: "Yellow-Smooth", "Yellow-Wrinkled", "Green-Smooth", "Green Wrinkled".
Parental Genotypes: SsGg × SsGg
Parental Gametes: SG, Sg, sG, sg
<span>
Smooth/Green </span>= S-G- = 9
<span>
Winkled/Green </span>= ssG- = 3
Smooth/Yellow = S-gg = 3
Wrinkled/Yellow = ssgg = 1
Ratio would be: 9: 3: 3: 1
Hope this helps!
Involuntary, meaning things in the body such as your heart is all regulated to act unconsciously while also receiving directives from the brain.
The post-eradication era is a period of history for which there has been no precedent whatsoever in terms of a zero base of immunity. Cessation of immunization will eventually create a population susceptible to widespread infection in the event of accidental or intentional reintroduction or re-emergence of the eradicated virus. Thus, even after immunization ceases, vaccine production must continue.
However, many currently available vaccines may not be appropriate for continued post-eradication vaccine production or reinstatement. Vaccines must be continually improved and ongoing vaccination research maintained. Other potentially useful antiviral strategies—antivirals, prophylaxis, and probiotics—must also be considered as means to strengthen the immune system and serve as adjuvant or prophylactic therapies.
In the case of polio, for example, it remains to be determined which vaccine (oral polio vaccine [OPV] or inactivated polio vaccine [IPV]), or variant thereof, should be produced in the post-eradication, post-vaccination era. A detailed plan for vaccine production will require more information on OPV-derived viral persistence and transmission, as well as continuing dialogue between public health and research communities in order to ensure that appropriate vaccination research continues.
